AR002905A1 - PHARMACEUTICAL COMPOSITIONS, SUITABLE TO DECREASE THE NUMBER OF CD8 + CELLS - Google Patents

PHARMACEUTICAL COMPOSITIONS, SUITABLE TO DECREASE THE NUMBER OF CD8 + CELLS

Info

Publication number
AR002905A1
AR002905A1 ARP960103677A AR10367796A AR002905A1 AR 002905 A1 AR002905 A1 AR 002905A1 AR P960103677 A ARP960103677 A AR P960103677A AR 10367796 A AR10367796 A AR 10367796A AR 002905 A1 AR002905 A1 AR 002905A1
Authority
AR
Argentina
Prior art keywords
cells
pharmaceutical compositions
decrease
compositions
isopropoxyisoflavone
Prior art date
Application number
ARP960103677A
Other languages
Spanish (es)
Inventor
Attila B Kovacs
Peter Aranyi
Teresie Kerepesi
Gyoergy Varai
Attila Tar
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of AR002905A1 publication Critical patent/AR002905A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)

Abstract

El presente invento se refiere a composiciones farmacéuticas, apropiadas para hacer disminuir la cantidad de células CD8+, que contienen en calidad decomponente activo la 7-isopropoxiisoflavona, en mezcla con excipientes inertes, sólidos o líquidos, y eventualmente con aditivos terapéuticos y sustanciasauxiliares. Estas composiciones se preparan por métodos conocidos y son apropiadas para tratar seres humanos o animales que se encuentran en unacondición en la que es deseable una supresión selectiva de linfocitos CD8+.The present invention relates to pharmaceutical compositions, suitable for reducing the amount of CD8 + cells, containing 7-isopropoxyisoflavone as an active component, in a mixture with inert solid or liquid excipients, and optionally with therapeutic additives and auxiliary substances. These compositions are prepared by known methods and are suitable for treating humans or animals in a condition where selective suppression of CD8 + lymphocytes is desirable.

ARP960103677A 1995-07-21 1996-07-22 PHARMACEUTICAL COMPOSITIONS, SUITABLE TO DECREASE THE NUMBER OF CD8 + CELLS AR002905A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9502198A HU9502198D0 (en) 1995-07-21 1995-07-21 Novel indication

Publications (1)

Publication Number Publication Date
AR002905A1 true AR002905A1 (en) 1998-04-29

Family

ID=10987063

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960103677A AR002905A1 (en) 1995-07-21 1996-07-22 PHARMACEUTICAL COMPOSITIONS, SUITABLE TO DECREASE THE NUMBER OF CD8 + CELLS

Country Status (22)

Country Link
EP (1) EP0841915A1 (en)
JP (1) JP2001503371A (en)
KR (1) KR19990028933A (en)
CN (1) CN1191483A (en)
AR (1) AR002905A1 (en)
AU (1) AU6367096A (en)
BG (1) BG102182A (en)
BR (1) BR9610187A (en)
CA (1) CA2227421A1 (en)
CZ (1) CZ2798A3 (en)
EA (1) EA199800146A1 (en)
EE (1) EE9800020A (en)
HR (1) HRP960345A2 (en)
HU (1) HU9502198D0 (en)
IL (1) IL122751A0 (en)
MX (1) MX9800603A (en)
NO (1) NO980127D0 (en)
PL (1) PL324460A1 (en)
SK (1) SK3298A3 (en)
WO (1) WO1997003664A1 (en)
YU (1) YU42796A (en)
ZA (1) ZA966079B (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1241079B (en) * 1990-03-23 1993-12-29 Chiesi Farma Spa PHARMACEUTICAL COMPOSITIONS CONTAINING IPRIFLAVONE, PROCEDURE FOR THEIR PREPARATION AND RELATED THERAPEUTIC USE
HU212932B (en) * 1993-08-02 1996-12-30 Chinoin Gyogyszer Es Vegyeszet Parmaceutical composition containing ipriflavone, hydroxyapatit and tricalciumphosphate for treating lack of bones and process for producing the composition

Also Published As

Publication number Publication date
WO1997003664A8 (en) 1999-08-05
CZ2798A3 (en) 1998-06-17
JP2001503371A (en) 2001-03-13
PL324460A1 (en) 1998-05-25
EA199800146A1 (en) 1998-08-27
NO980127L (en) 1998-01-12
MX9800603A (en) 1998-04-30
BR9610187A (en) 1998-07-28
SK3298A3 (en) 1998-07-08
EE9800020A (en) 1998-08-17
ZA966079B (en) 1998-01-19
BG102182A (en) 1998-08-31
IL122751A0 (en) 1998-08-16
HRP960345A2 (en) 1998-02-28
HU9502198D0 (en) 1995-09-28
EP0841915A1 (en) 1998-05-20
AU6367096A (en) 1997-02-18
WO1997003664A1 (en) 1997-02-06
KR19990028933A (en) 1999-04-15
YU42796A (en) 1999-03-04
CN1191483A (en) 1998-08-26
CA2227421A1 (en) 1997-02-06
NO980127D0 (en) 1998-01-12

Similar Documents

Publication Publication Date Title
KR960706344A (en) MEANS AND METHOD FOR HORMONAL CONTRACEPTION AND / OR THE TREATMENT OF ACNE
TW283645B (en)
CA2366702A1 (en) Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
YU86001A (en) Novel preparation and administration form comprising an acid-labile active compound
ES2185179T3 (en) PREPARATION OF PHARMACEUTICAL COMPOSITIONS.
GR3036211T3 (en) Taxane class derivative based pharmaceutical compositions
WO2001030802A3 (en) Therapeutic treatments comprising administration of certain steroids for blood cell deficiencies
IL157841A0 (en) Activation of natural killer cells by adenosine a3 receptor agonists
KR970705553A (en) Dihydrobenzofuran, and related compounds useful as anti-inflammatory drugs (DIHYDROBENZOFURAN AND RELATED COMPOUNDS USEFUL AS ANTI-INFLAMMATORY AGENTS)
DE69805983D1 (en) COUGH-RESISTANT COMPOSITIONS CONTAINING THEOBROMINE
ES2134237T3 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING URSODESOXICOLICO ACID.
AR002905A1 (en) PHARMACEUTICAL COMPOSITIONS, SUITABLE TO DECREASE THE NUMBER OF CD8 + CELLS
DK1509523T3 (en) Triazaspiro compounds useful for treating or preventing pain
ATE173624T1 (en) SYNERGISTIC PHARMACEUTICAL COMPOSITIONS CONTAINING TRIAMCINOLONEACETONIDE AND HALCINONIDE
ES2172179T3 (en) PHARMACEUTICAL COMPOSITIONS OF CONTROLLED RELEASE CONTAINING THIAGABINE.
ATE24111T1 (en) MIXTURE CONTAINING A CENTRAL ANALGESIC AND VITAMINS B12 OR ONE OF ITS ANALOGUES AS ACTIVE INGREDIENTS.
ES2162022T3 (en) TIOL DERIVATIVES WITH INHIBITING ACTIVITY OF METALOPEPTIDASA.
GEP20053581B (en) Pharmaceutical Composition and Method for Preparation Thereof
AR027038A1 (en) METHOD AND COMPOSITION FOR PAIN TREATMENT
CO4750838A1 (en) METHOD FOR THE TREATMENT OF ADVERSE INFLAMMATORY REACTIONS AND ADMINISTERED ANTI-INFLAMMATORY COMPOSITION
CA2216700A1 (en) Synergistic pharmaceutical compositions containing triamcinolone acetonide and halcinonide
GT199500028A (en) PROCEDURE TO PREPARE A SELECTIVE HERBICIDE SOLUTION
KR950005312A (en) Pharmaceutical composition for treating liver disease and improving liver function